TreeWAS – Variant ID: rs801112

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability
Chapter II Neoplasms	0.083	0.917
C50.9 Breast, unspecified	0.083	0.917
C50 Malignant neoplasm of breast	0.082	0.918
C50-C50 Malignant neoplasm of breast	0.082	0.918
D10-D36 Benign neoplasms	0.081	0.919
D12 Benign neoplasm of colon, rectum, anus and anal canal	0.078	0.922
D12.3 Transverse colon	0.076	0.924
D24 Benign neoplasm of breast	0.072	0.928
# Top node	0.070	0.930
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.068	0.932
C15-C26 Malignant neoplasms of digestive organs	0.067	0.933
D12.7 Rectosigmoid junction	0.067	0.933
D22 Melanocytic naevi	0.065	0.935
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.065	0.935
C50.8 Overlapping lesion of breast	0.065	0.935
Chapter XIX Injury, poisoning and certain other consequences of external causes	0.065	0.935
Chapter VII Diseases of the eye and adnexa	0.064	0.936
D37-D48 Neoplasms of uncertain or unknown behaviour	0.064	0.936
D23 Other benign neoplasms of skin	0.064	0.936
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.063	0.937
D17 Benign lipomatous neoplasm	0.062	0.938
C43-C44 Melanoma and other malignant neoplasms of skin	0.062	0.938
D12.4 Descending colon	0.062	0.938
D12.0 Caecum	0.062	0.938
C50.3 Lower-inner quadrant of breast	0.062	0.938
Chapter IX Diseases of the circulatory system	0.061	0.939
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.060	0.940
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.060	0.940
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.060	0.940
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.060	0.940
C40-C41 Malignant neoplasms of bone and articular cartilage	0.060	0.940
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.060	0.940
D36 Benign neoplasm of other and unspecified sites	0.059	0.941
D12.2 Ascending colon	0.059	0.941
C50.6 Axillary tail of breast	0.059	0.941
C50.5 Lower-outer quadrant of breast	0.059	0.941
C50.1 Central portion of breast	0.059	0.941
C50.0 Nipple and areola	0.059	0.941
C50.4 Upper-outer quadrant of breast	0.059	0.941
Chapter VI Diseases of the nervous system	0.059	0.941
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.059	0.941
D35 Benign neoplasm of other and unspecified endocrine glands	0.058	0.941
D33 Benign neoplasm of brain and other parts of central nervous system	0.058	0.941
D32 Benign neoplasm of meninges	0.058	0.941
D31 Benign neoplasm of eye and adnexa	0.058	0.941
D30 Benign neoplasm of urinary organs	0.058	0.941
D29 Benign neoplasm of male genital organs	0.058	0.941
D28 Benign neoplasm of other and unspecified female genital organs	0.058	0.941
D26 Other benign neoplasms of uterus	0.058	0.941
D21 Other benign neoplasms of connective and other soft tissue	0.058	0.941
D20 Benign neoplasm of soft tissue of retroperitoneum and peritoneum	0.058	0.941
D19 Benign neoplasm of mesothelial tissue	0.058	0.941
D16 Benign neoplasm of bone and articular cartilage	0.058	0.941
D15 Benign neoplasm of other and unspecified intrathoracic organs	0.058	0.941
D14 Benign neoplasm of middle ear and respiratory system	0.058	0.941
D11 Benign neoplasm of major salivary glands	0.058	0.941
D10 Benign neoplasm of mouth and pharynx	0.058	0.941
D34 Benign neoplasm of thyroid gland	0.058	0.941
S00-S09 Injuries to the head	0.058	0.942
D18 Haemangioma and lymphangioma, any site	0.058	0.942
D13 Benign neoplasm of other and ill-defined parts of digestive system	0.058	0.942
H53-H54 Visual disturbances and blindness	0.058	0.942
Chapter XII Diseases of the skin and subcutaneous tissue	0.057	0.943
I60-I69 Cerebrovascular diseases	0.057	0.943
C18 Malignant neoplasm of colon	0.057	0.943
C51-C58 Malignant neoplasms of female genital organs	0.056	0.943
Chapter I Certain infectious and parasitic diseases	0.056	0.944
D12.9 Anus and anal canal	0.056	0.944
D12.1 Appendix	0.056	0.944
C90 Multiple myeloma and malignant plasma cell neoplasms	0.055	0.945
T36-T50 Poisoning by drugs, medicaments and biological substances	0.055	0.945
C43 Malignant melanoma of skin	0.055	0.945
T29-T32 Burns and corrosions of multiple and unspecified body regions	0.054	0.945
D22.7 Melanocytic naevi of lower limb, including hip	0.054	0.946
D23.7 Skin of lower limb, including hip	0.054	0.946
C81 Hodgkin's disease	0.054	0.946
H30-H36 Disorders of choroid and retina	0.054	0.946
I63 Cerebral infarction	0.054	0.946
C50.2 Upper-inner quadrant of breast	0.053	0.947
C79 Secondary malignant neoplasm of other sites	0.053	0.947
D17.2 Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs	0.052	0.948
G40-G47 Episodic and paroxysmal disorders	0.052	0.948
D23.6 Skin of upper limb, including shoulder	0.052	0.948
C15 Malignant neoplasm of oesophagus	0.052	0.948
L00-L08 Infections of the skin and subcutaneous tissue	0.052	0.948
Chapter XV Pregnancy, childbirth and the puerperium	0.052	0.948
Chapter XIII Diseases of the musculoskeletal system and connective tissue	0.052	0.948
D22.1 Melanocytic naevi of eyelid, including canthus	0.051	0.948
H53 Visual disturbances	0.051	0.949
D70-D77 Other diseases of blood and blood-forming organs	0.051	0.949
D00-D09 In situ neoplasms	0.051	0.949
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.051	0.949
H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction	0.051	0.949
T66-T78 Other and unspecified effects of external causes	0.051	0.949
S00 Superficial injury of head	0.051	0.949
I63.9 Cerebral infarction, unspecified	0.050	0.949
D45 Polycythaemia vera	0.050	0.949
Chapter XXII Codes for special purposes	0.050	0.950
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.050	0.950
Chapter XVI Certain conditions originating in the perinatal period	0.050	0.950
H55-H59 Other disorders of eye and adnexa	0.050	0.950
D27 Benign neoplasm of ovary	0.050	0.950
C64-C68 Malignant neoplasms of urinary tract	0.050	0.950
C25 Malignant neoplasm of pancreas	0.050	0.950
D22.4 Melanocytic naevi of scalp and neck	0.050	0.950
A30-A49 Other bacterial diseases	0.050	0.950
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes	0.049	0.950
I95-I99 Other and unspecified disorders of the circulatory system	0.049	0.951
H40-H42 Glaucoma	0.049	0.951
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.049	0.951
C95 Leukaemia of unspecified cell type	0.049	0.951
C94 Other leukaemias of specified cell type	0.049	0.951
C93 Monocytic leukaemia	0.049	0.951
C92 Myeloid leukaemia	0.049	0.951
C91 Lymphoid leukaemia	0.049	0.951
C88 Malignant immunoproliferative diseases	0.049	0.951
C86 Other specified types of T/NK-cell lymphoma	0.049	0.951
C84 Peripheral and cutaneous T-cell lymphomas	0.049	0.951
C83 Diffuse non-Hodgkin's lymphoma	0.049	0.951
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.049	0.951
M20-M25 Other joint disorders	0.049	0.951
S30-S39 Injuries to the abdomen, lower back, lumbar spine and pelvis	0.049	0.951
C19 Malignant neoplasm of rectosigmoid junction	0.049	0.951
Chapter X Diseases of the respiratory system	0.049	0.951
D17.1 Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk	0.048	0.951
C26 Malignant neoplasm of other and ill-defined digestive organs	0.048	0.952
C24 Malignant neoplasm of other and unspecified parts of biliary tract	0.048	0.952
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.048	0.952
C21 Malignant neoplasm of anus and anal canal	0.048	0.952
C17 Malignant neoplasm of small intestine	0.048	0.952
C16 Malignant neoplasm of stomach	0.048	0.952
C23 Malignant neoplasm of gallbladder	0.048	0.952
C34 Malignant neoplasm of bronchus and lung	0.048	0.952
L40-L45 Papulosquamous disorders	0.048	0.952
I67 Other cerebrovascular diseases	0.048	0.952
C43.6 Malignant melanoma of upper limb, including shoulder	0.048	0.952
G40 Epilepsy	0.048	0.952
C60-C63 Malignant neoplasms of male genital organs	0.047	0.952
T31 Burns classified according to extent of body surface involved	0.047	0.953
D60-D64 Aplastic and other anaemias	0.047	0.953
I30-I52 Other forms of heart disease	0.047	0.953
D22.9 Melanocytic naevi, unspecified	0.047	0.953
D22.6 Melanocytic naevi of upper limb, including shoulder	0.047	0.953
D22.2 Melanocytic naevi of ear and external auricular canal	0.047	0.953
D22.0 Melanocytic naevi of lip	0.047	0.953
C80 Malignant neoplasm without specification of site	0.047	0.953
C76 Malignant neoplasm of other and ill-defined sites	0.047	0.953
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.047	0.953
S20-S29 Injuries to the thorax	0.047	0.953
K57.3 Diverticular disease of large intestine without perforation or abscess	0.047	0.953
T79-T79 Certain early complications of trauma	0.046	0.953
T33-T35 Frostbite	0.046	0.953
T26-T28 Burns and corrosions confined to eye and internal organs	0.046	0.953
T20-T25 Burns and corrosions of external body surface, specified by site	0.046	0.953
T15-T19 Effects of foreign body entering through natural orifice	0.046	0.953
T08-T14 Injuries to unspecified part of trunk, limb or body region	0.046	0.953
T00-T07 Injuries involving multiple body regions	0.046	0.953
S90-S99 Injuries to the ankle and foot	0.046	0.953
S10-S19 Injuries to the neck	0.046	0.953
C90.0 Multiple myeloma	0.046	0.954
D70 Agranulocytosis	0.046	0.954
G35-G37 Demyelinating diseases of the central nervous system	0.046	0.954
H46-H48 Disorders of optic nerve and visual pathways	0.046	0.954
H15-H22 Disorders of sclera, cornea, iris and ciliary body	0.046	0.954
H10-H13 Disorders of conjunctiva	0.046	0.954
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites	0.046	0.954
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.046	0.954
D46 Myelodysplastic syndromes	0.046	0.954
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands	0.046	0.954
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system	0.046	0.954
D42 Neoplasm of uncertain or unknown behaviour of meninges	0.046	0.954
D41 Neoplasm of uncertain or unknown behaviour of urinary organs	0.046	0.954
D40 Neoplasm of uncertain or unknown behaviour of male genital organs	0.046	0.954
D39 Neoplasm of uncertain or unknown behaviour of female genital organs	0.046	0.954
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs	0.046	0.954
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs	0.046	0.954
D23.9 Skin, unspecified	0.046	0.954
D23.4 Skin of scalp and neck	0.046	0.954
D23.2 Skin of ear and external auricular canal	0.046	0.954
D23.0 Skin of lip	0.046	0.954
S50-S59 Injuries to the elbow and forearm	0.046	0.954
C18.7 Sigmoid colon	0.046	0.954
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.046	0.954
H33 Retinal detachments and breaks	0.046	0.954
I64 Stroke, not specified as haemorrhage or infarction	0.046	0.954
I05-I09 Chronic rheumatic heart diseases	0.046	0.954
C18.9 Colon, unspecified	0.046	0.954
S00.8 Superficial injury of other parts of head	0.045	0.954
H54 Blindness and low vision	0.045	0.954
G10-G14 Systemic atrophies primarily affecting the central nervous system	0.045	0.955
C77.3 Axillary and upper limb lymph nodes	0.045	0.955
S80-S89 Injuries to the knee and lower leg	0.045	0.955
H43-H45 Disorders of vitreous body and globe	0.045	0.955
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs	0.045	0.955
C38 Malignant neoplasm of heart, mediastinum and pleura	0.045	0.955
C32 Malignant neoplasm of larynx	0.045	0.955
C31 Malignant neoplasm of accessory sinuses	0.045	0.955
C30 Malignant neoplasm of nasal cavity and middle ear	0.045	0.955
C37 Malignant neoplasm of thymus	0.045	0.955
C33 Malignant neoplasm of trachea	0.045	0.955
D17.9 Benign lipomatous neoplasm, unspecified	0.045	0.955
D17.7 Benign lipomatous neoplasm of other sites	0.045	0.955
D17.5 Benign lipomatous neoplasm of intra-abdominal organs	0.045	0.955
D17.4 Benign lipomatous neoplasm of intrathoracic organs	0.045	0.955
D17.3 Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites	0.045	0.955
S06 Intracranial injury	0.045	0.955
I70-I79 Diseases of arteries, arterioles and capillaries	0.045	0.955
G90-G99 Other disorders of the nervous system	0.044	0.955
L03 Cellulitis	0.045	0.955
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.044	0.955
I20-I25 Ischaemic heart diseases	0.045	0.955
S70-S79 Injuries to the hip and thigh	0.044	0.956
D23.5 Skin of trunk	0.044	0.956
S02 Fracture of skull and facial bones	0.044	0.956
M20 Acquired deformities of fingers and toes	0.044	0.956
C79.5 Secondary malignant neoplasm of bone and bone marrow	0.044	0.956
M25 Other joint disorders, not elsewhere classified	0.044	0.956
I00-I02 Acute rheumatic fever	0.044	0.956
S60-S69 Injuries to the wrist and hand	0.044	0.956
C81.9 Hodgkin's disease, unspecified	0.044	0.956
D25 Leiomyoma of uterus	0.044	0.956
D36.1 Peripheral nerves and autonomic nervous system	0.043	0.956
H53.1 Subjective visual disturbances	0.044	0.956
S40-S49 Injuries to the shoulder and upper arm	0.043	0.956
Chapter VIII Diseases of the ear and mastoid process	0.043	0.957
D80-D89 Certain disorders involving the immune mechanism	0.043	0.957
D12.6 Colon, unspecified	0.043	0.957
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.043	0.957
B35-B49 Mycoses	0.043	0.957
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx	0.043	0.957
C13 Malignant neoplasm of hypopharynx	0.043	0.957
C11 Malignant neoplasm of nasopharynx	0.043	0.957
C10 Malignant neoplasm of oropharynx	0.043	0.957
C09 Malignant neoplasm of tonsil	0.043	0.957
C08 Malignant neoplasm of other and unspecified major salivary glands	0.043	0.957
C06 Malignant neoplasm of other and unspecified parts of mouth	0.043	0.957
C05 Malignant neoplasm of palate	0.043	0.957
C04 Malignant neoplasm of floor of mouth	0.043	0.957
C03 Malignant neoplasm of gum	0.043	0.957
C02 Malignant neoplasm of other and unspecified parts of tongue	0.043	0.957
C00 Malignant neoplasm of lip	0.043	0.957
C12 Malignant neoplasm of pyriform sinus	0.043	0.957
C07 Malignant neoplasm of parotid gland	0.043	0.957
C01 Malignant neoplasm of base of tongue	0.043	0.957
C42 hematopoietic and reticuloendothelial systems (ICD-O-3 specific)	0.043	0.957
C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites	0.043	0.957
C40 Malignant neoplasm of bone and articular cartilage of limbs	0.043	0.957
C49 Malignant neoplasm of other connective and soft tissue	0.043	0.957
C48 Malignant neoplasm of retroperitoneum and peritoneum	0.043	0.957
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system	0.043	0.957
C46 Kaposi's sarcoma	0.043	0.957
C45 Mesothelioma	0.043	0.957
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system	0.043	0.957
C71 Malignant neoplasm of brain	0.043	0.957
C70 Malignant neoplasm of meninges	0.043	0.957
C69 Malignant neoplasm of eye and adnexa	0.043	0.957
C75 Malignant neoplasm of other endocrine glands and related structures	0.043	0.957
C74 Malignant neoplasm of adrenal gland	0.043	0.957
C73 Malignant neoplasm of thyroid gland	0.043	0.957
C97 Malignant neoplasms of independent (primary) multiple sites	0.043	0.957
D12.5 Sigmoid colon	0.043	0.957
D36.9 Benign neoplasm of unspecified site	0.043	0.957
D36.7 Other specified sites	0.043	0.957
D36.0 Lymph nodes	0.043	0.957
S09 Other and unspecified injuries of head	0.043	0.957
D22.5 Melanocytic naevi of trunk	0.043	0.957
D17.6 Benign lipomatous neoplasm of spermatic cord	0.043	0.957
G44 Other headache syndromes	0.042	0.957
G70-G73 Diseases of myoneural junction and muscle	0.042	0.958
G30-G32 Other degenerative diseases of the nervous system	0.042	0.958
G00-G09 Inflammatory diseases of the central nervous system	0.042	0.958
S01 Open wound of head	0.042	0.958
T31.0 Burns involving less than 10% of body surface	0.042	0.958
C56 Malignant neoplasm of ovary	0.042	0.958
D55-D59 Haemolytic anaemias	0.042	0.958
D10.9 Pharynx, unspecified	0.042	0.958
D10.7 Hypopharynx	0.042	0.958
D10.6 Nasopharynx	0.042	0.958
D10.5 Other parts of oropharynx	0.042	0.958
D10.4 Tonsil	0.042	0.958
D10.3 Other and unspecified parts of mouth	0.042	0.958
D10.2 Floor of mouth	0.042	0.958
D10.1 Tongue	0.042	0.958
D10.0 Lip	0.042	0.958
D11.9 Major salivary gland, unspecified	0.042	0.958
D11.7 Other major salivary glands	0.042	0.958
D11.0 Parotid gland	0.042	0.958
D14.4 Respiratory system, unspecified	0.042	0.958
D14.3 Bronchus and lung	0.042	0.958
D14.2 Trachea	0.042	0.958
D14.1 Larynx	0.042	0.958
D14.0 Middle ear, nasal cavity and accessory sinuses	0.042	0.958
D15.9 Intrathoracic organ, unspecified	0.042	0.958
D15.7 Other specified intrathoracic organs	0.042	0.958
D15.2 Mediastinum	0.042	0.958
D15.1 Heart	0.042	0.958
D15.0 Thymus	0.042	0.958
D16.9 Bone and articular cartilage, unspecified	0.042	0.958
D16.8 Pelvic bones, sacrum and coccyx	0.042	0.958
D16.7 Ribs, sternum and clavicle	0.042	0.958
D16.6 Vertebral column	0.042	0.958
D16.5 Lower jaw bone	0.042	0.958
D16.4 Bones of skull and face	0.042	0.958
D16.3 Short bones of lower limb	0.042	0.958
D16.2 Long bones of lower limb	0.042	0.958
D16.1 Short bones of upper limb	0.042	0.958
D16.0 Scapula and long bones of upper limb	0.042	0.958
D19.9 Mesothelial tissue, unspecified	0.042	0.958
D19.7 Mesothelial tissue of other sites	0.042	0.958
D19.1 Mesothelial tissue of peritoneum	0.042	0.958
D19.0 Mesothelial tissue of pleura	0.042	0.958
D20.1 Peritoneum	0.042	0.958
D20.0 Retroperitoneum	0.042	0.958
D21.9 Connective and other soft tissue, unspecified	0.042	0.958
D21.6 Connective and other soft tissue of trunk, unspecified	0.042	0.958
D21.5 Connective and other soft tissue of pelvis	0.042	0.958
D21.4 Connective and other soft tissue of abdomen	0.042	0.958
D21.3 Connective and other soft tissue of thorax	0.042	0.958
D21.2 Connective and other soft tissue of lower limb, including hip	0.042	0.958
D21.1 Connective and other soft tissue of upper limb, including shoulder	0.042	0.958
D21.0 Connective and other soft tissue of head, face and neck	0.042	0.958
D26.9 Uterus, unspecified	0.042	0.958
D26.7 Other parts of uterus	0.042	0.958
D26.1 Corpus uteri	0.042	0.958
D26.0 Cervix uteri	0.042	0.958
D28.9 Female genital organ, unspecified	0.042	0.958
D28.7 Other specified female genital organs	0.042	0.958
D28.2 Uterine tubes and ligaments	0.042	0.958
D28.1 Vagina	0.042	0.958
D28.0 Vulva	0.042	0.958
D29.9 Male genital organ, unspecified	0.042	0.958
D29.7 Other male genital organs	0.042	0.958
D29.4 Scrotum	0.042	0.958
D29.3 Epididymis	0.042	0.958
D29.2 Testis	0.042	0.958
D29.1 Prostate	0.042	0.958
D29.0 Penis	0.042	0.958
D30.9 Urinary organ, unspecified	0.042	0.958
D30.7 Other urinary organs	0.042	0.958
D30.4 Urethra	0.042	0.958
D30.3 Bladder	0.042	0.958
D30.2 Ureter	0.042	0.958
D30.1 Renal pelvis	0.042	0.958
D30.0 Kidney	0.042	0.958
D31.9 Eye, unspecified	0.042	0.958
D31.6 Orbit, unspecified	0.042	0.958
D31.5 Lachrymal gland and duct	0.042	0.958
D31.4 Ciliary body	0.042	0.958
D31.3 Choroid	0.042	0.958
D31.2 Retina	0.042	0.958
D31.1 Cornea	0.042	0.958
D31.0 Conjunctiva	0.042	0.958
D32.9 Meninges, unspecified	0.042	0.958
D32.1 Spinal meninges	0.042	0.958
D32.0 Cerebral meninges	0.042	0.958
D33.9 Central nervous system, unspecified	0.042	0.958
D33.7 Other specified parts of central nervous system	0.042	0.958
D33.4 Spinal cord	0.042	0.958
D33.3 Cranial nerves	0.042	0.958
D33.2 Brain, unspecified	0.042	0.958
D33.1 Brain, infratentorial	0.042	0.958
D33.0 Brain, supratentorial	0.042	0.958
D35.9 Endocrine gland, unspecified	0.042	0.958
D35.8 Pluriglandular involvement	0.042	0.958
D35.7 Other specified endocrine glands	0.042	0.958
D35.6 Aortic body and other paraganglia	0.042	0.958
D35.5 Carotid body	0.042	0.958
D35.4 Pineal gland	0.042	0.958
D35.3 Craniopharyngeal duct	0.042	0.958
D35.2 Pituitary gland	0.042	0.958
D35.1 Parathyroid gland	0.042	0.958
D35.0 Adrenal gland	0.042	0.958
M20.1 Hallux valgus (acquired)	0.042	0.958
M70-M79 Other soft tissue disorders	0.042	0.958
C43.7 Malignant melanoma of lower limb, including hip	0.042	0.958
O00-O08 Pregnancy with abortive outcome	0.042	0.958
S08 Traumatic amputation of part of head	0.042	0.958
S07 Crushing injury of head	0.042	0.958
S05 Injury of eye and orbit	0.042	0.958
S04 Injury of cranial nerves	0.042	0.958
S03 Dislocation, sprain and strain of joints and ligaments of head	0.042	0.958
D18.1 Lymphangioma, any site	0.042	0.958
A49 Bacterial infection of unspecified site	0.042	0.958
G80-G83 Cerebral palsy and other paralytic syndromes	0.042	0.958
D23.3 Skin of other and unspecified parts of face	0.042	0.958
D13.9 Ill-defined sites within the digestive system	0.041	0.958
D13.7 Endocrine pancreas	0.041	0.958
D13.6 Pancreas	0.041	0.958
D13.5 Extrahepatic bile ducts	0.041	0.958
D13.4 Liver	0.041	0.958
D13.3 Other and unspecified parts of small intestine	0.041	0.958
D13.2 Duodenum	0.041	0.958
D13.0 Oesophagus	0.041	0.958
I26-I28 Pulmonary heart disease and diseases of pulmonary circulation	0.042	0.958
I63.5 Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries	0.041	0.958
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.041	0.958
L50-L54 Urticaria and erythema	0.041	0.959
L10-L14 Bullous disorders	0.041	0.959
A41 Other septicaemia	0.041	0.959
I68 Cerebrovascular disorders in diseases classified elsewhere	0.041	0.959
I66 Occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction	0.041	0.959
I62 Other nontraumatic intracranial haemorrhage	0.041	0.959
I61 Intracerebral haemorrhage	0.041	0.959
D18.0 Haemangioma, any site	0.041	0.959
H52 Disorders of refraction and accommodation	0.041	0.959
L08 Other local infections of skin and subcutaneous tissue	0.041	0.959
Chapter XX External causes of morbidity and mortality	0.041	0.959
H36 Retinal disorders in diseases classified elsewhere	0.041	0.959
T78 Adverse effects, not elsewhere classified	0.041	0.959
H33.3 Retinal breaks without detachment	0.041	0.959
C20 Malignant neoplasm of rectum	0.041	0.959
T42.4 Benzodiazepines	0.041	0.959
C18.8 Overlapping lesion of colon	0.041	0.959
C18.6 Descending colon	0.041	0.959
C18.5 Splenic flexure	0.041	0.959
C18.4 Transverse colon	0.041	0.959
C18.3 Hepatic flexure	0.041	0.959
C18.2 Ascending colon	0.041	0.959
C18.1 Appendix	0.041	0.959
C18.0 Caecum	0.041	0.959
K57 Diverticular disease of intestine	0.041	0.959
Chapter IV Endocrine, nutritional and metabolic diseases	0.041	0.959
G40.2 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures	0.041	0.959
C57 Malignant neoplasm of other and unspecified female genital organs	0.041	0.959
C53 Malignant neoplasm of cervix uteri	0.041	0.959
C51 Malignant neoplasm of vulva	0.041	0.959
C58 Malignant neoplasm of placenta	0.041	0.959
C55 Malignant neoplasm of uterus, part unspecified	0.041	0.959
C52 Malignant neoplasm of vagina	0.041	0.959
H25-H28 Disorders of lens	0.041	0.959
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions	0.041	0.959
D13.1 Stomach	0.041	0.959
I95 Hypotension	0.041	0.959
I49 Other cardiac arrhythmias	0.041	0.959
I60 Subarachnoid haemorrhage	0.040	0.959
O20-O29 Other maternal disorders predominantly related to pregnancy	0.040	0.959
H53.4 Visual field defects	0.040	0.959
D22.3 Melanocytic naevi of other and unspecified parts of face	0.040	0.960
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.040	0.960
B99-B99 Other infectious diseases	0.040	0.960
B90-B94 Sequelae of infectious and parasitic diseases	0.040	0.960
B85-B89 Pediculosis, acariasis and other infestations	0.040	0.960
B65-B83 Helminthiases	0.040	0.960
B50-B64 Protozoal diseases	0.040	0.960
B25-B34 Other viral diseases	0.040	0.960
B20-B24 Human immunodeficiency virus [HIV] disease	0.040	0.960
B15-B19 Viral hepatitis	0.040	0.960
A92-A99 Arthropod-borne viral fevers and viral haemorrhagic fevers	0.040	0.960
A80-A89 Viral infections of the central nervous system	0.040	0.960
A75-A79 Rickettsioses	0.040	0.960
A70-A74 Other diseases caused by chlamydiae	0.040	0.960
A65-A69 Other spirochaetal diseases	0.040	0.960
A50-A64 Infections with a predominantly sexual mode of transmission	0.040	0.960
A20-A28 Certain zoonotic bacterial diseases	0.040	0.960
A15-A19 Tuberculosis	0.040	0.960
G60-G64 Polyneuropathies and other disorders of the peripheral nervous system	0.040	0.960
M95-M99 Other disorders of the musculoskeletal system and connective tissue	0.040	0.960
H59 Postprocedural disorders of eye and adnexa, not elsewhere classified	0.040	0.960
C43.5 Malignant melanoma of trunk	0.040	0.960
C90.3 Solitary plasmacytoma	0.040	0.960
C90.2 Plasmacytoma, extramedullary	0.040	0.960
C90.1 Plasma cell leukaemia	0.040	0.960
I35 Nonrheumatic aortic valve disorders	0.040	0.960
L20-L30 Dermatitis and eczema	0.040	0.960
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.040	0.960
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.040	0.960
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.040	0.960
T46 Poisoning by agents primarily affecting the cardiovascular system	0.040	0.960
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.040	0.960
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.040	0.960
T41 Poisoning by anaesthetics and therapeutic gases	0.040	0.960
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.040	0.960
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.040	0.960
T36 Poisoning by systemic antibiotics	0.040	0.960
L40 Psoriasis	0.040	0.960
Chapter XI Diseases of the digestive system	0.040	0.960
M25.5 Pain in joint	0.039	0.960
C43.9 Malignant melanoma of skin, unspecified	0.039	0.961
C43.8 Overlapping malignant melanoma of skin	0.039	0.961
C43.4 Malignant melanoma of scalp and neck	0.039	0.961
C43.3 Malignant melanoma of other and unspecified parts of face	0.039	0.961
C43.2 Malignant melanoma of ear and external auricular canal	0.039	0.961
C43.1 Malignant melanoma of eyelid, including canthus	0.039	0.961
C43.0 Malignant melanoma of lip	0.039	0.961
M80-M85 Disorders of bone density and structure	0.039	0.961
O94-O99 Other obstetric conditions, not elsewhere classified	0.039	0.961
T32 Corrosions classified according to extent of body surface involved	0.039	0.961
T30 Burn and corrosion, body region unspecified	0.039	0.961
T29 Burns and corrosions of multiple body regions	0.039	0.961
C15.9 Oesophagus, unspecified	0.039	0.961
L02 Cutaneous abscess, furuncle and carbuncle	0.039	0.961
M31 Other necrotising vasculopathies	0.039	0.961
C15.5 Lower third of oesophagus	0.039	0.961
L05 Pilonidal cyst	0.039	0.961
B00-B09 Viral infections characterized by skin and mucous membrane lesions	0.039	0.961
G40.6 Grand mal seizures, unspecified (with or without petit mal)	0.039	0.961
G20-G26 Extrapyramidal and movement disorders	0.039	0.961
J60-J70 Lung diseases due to external agents	0.039	0.961
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.039	0.961
C81.7 Other Hodgkin's disease	0.039	0.961

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations